Literature DB >> 24821129

Advances in the diagnosis and therapeutic management of atopic dermatitis.

Christian Vestergaard1, Mette Deleuran.   

Abstract

Atopic dermatitis is a very prevalent disease that affects children as well as adults. The disease has a severe impact on quality of life for the patients and their families. The skin in atopic dermatitis patients is a site of both a severe inflammatory reaction dominated by lymphocytes and decreased skin barrier function. The treatment of the disease is mainly aimed at reducing the inflammation in the skin and/or restoring the skin barrier function. However, most of the treatments used today singularly aim at reducing the inflammation in the skin. Depending on the severity of the disease, the anti-inflammatory treatment may be topical or systemic, but basic treatment, no matter the severity, should always be emollients. In addition, new studies have shown good effects of psychosocial interventions, such as eczema schools, for patients and their families. This review covers the latest trends in the treatment of atopic dermatitis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24821129     DOI: 10.1007/s40265-014-0219-3

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   11.431


  123 in total

1.  A randomized trial of methotrexate versus azathioprine for severe atopic eczema.

Authors:  Mandy Elvira Schram; Evelien Roekevisch; Mariska Maria Geertruida Leeflang; Jan Dositheus Bos; Jochen Schmitt; Phyllis Ira Spuls
Journal:  J Allergy Clin Immunol       Date:  2011-04-22       Impact factor: 10.793

2.  An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.

Authors:  S C Weatherhead; S Wahie; N J Reynolds; S J Meggitt
Journal:  Br J Dermatol       Date:  2007-02       Impact factor: 9.302

3.  Anti-CD20 (rituximab) treatment for atopic eczema.

Authors:  Anna Sedivá; Jana Kayserová; Eva Vernerová; Andrea Poloucková; Stepánka Capková; Radek Spísek; Jirina Bartůnková
Journal:  J Allergy Clin Immunol       Date:  2008-04-14       Impact factor: 10.793

4.  Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study.

Authors:  Peter Maximilian Heil; Dieter Maurer; Brigitte Klein; Thomas Hultsch; Georg Stingl
Journal:  J Dtsch Dermatol Ges       Date:  2010-12       Impact factor: 5.584

5.  Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract--a new therapeutic option for patients with atopic dermatitis.

Authors:  Natalija Novak; Diamant Thaci; Matthias Hoffmann; Regina Fölster-Holst; Thilo Biedermann; Bernhard Homey; Knut Schaekel; Josef A Stefan; Thomas Werfel; Thomas Bieber; Angelika Sager; Torsten Zuberbier
Journal:  Int Arch Allergy Immunol       Date:  2011-02-02       Impact factor: 2.749

Review 6.  Effect of nutrient supplementation on atopic dermatitis in children: a systematic review of probiotics, prebiotics, formula, and fatty acids.

Authors:  Negar Foolad; Elizabeth A Brezinski; Elizabeth P Chase; April W Armstrong
Journal:  JAMA Dermatol       Date:  2013-03       Impact factor: 10.282

7.  Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation.

Authors:  Kei Ikeda; Hiroshi Nakajima; Kotaro Suzuki; Shin-ichiro Kagami; Koichi Hirose; Akira Suto; Yasushi Saito; Itsuo Iwamoto
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

8.  Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study.

Authors:  John Berth-Jones; Robert J Damstra; Stefan Golsch; John K Livden; Oliver Van Hooteghem; Fulvio Allegra; Christine A Parker
Journal:  BMJ       Date:  2003-06-21

9.  Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production.

Authors:  P Parronchi; D Macchia; M P Piccinni; P Biswas; C Simonelli; E Maggi; M Ricci; A A Ansari; S Romagnani
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

Review 10.  Filaggrin in atopic dermatitis.

Authors:  Grainne M O'Regan; Aileen Sandilands; W H Irwin McLean; Alan D Irvine
Journal:  J Allergy Clin Immunol       Date:  2008-09-05       Impact factor: 10.793

View more
  4 in total

Review 1.  The diagnosis and graded therapy of atopic dermatitis.

Authors:  Thomas Werfel; Nicolaus Schwerk; Gesine Hansen; Alexander Kapp
Journal:  Dtsch Arztebl Int       Date:  2014-07-21       Impact factor: 5.594

2.  Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study.

Authors:  Jette Lindorff Riis; Christian Vestergaard; Kasper Fjellhaugen Hjuler; Lars Iversen; Lars Jakobsen; Mette S Deleuran; Morten Olsen
Journal:  BMJ Open       Date:  2016-11-11       Impact factor: 2.692

3.  Efficacy and Tolerability of a Medical Device Repairing Emollient Cream Associated with a Topical Corticosteroid in Adults with Atopic Dermatitis: An Open-label, Intra-individual Randomized Controlled Study.

Authors:  Ana Beatris Rossi; Adeline Bacquey; Thérèse Nocera; Marie-Dominique Thouvenin
Journal:  Dermatol Ther (Heidelb)       Date:  2018-03-06

4.  Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis.

Authors:  Tamara Quint; Patrick M Brunner; Christoph Sinz; Irene Steiner; Robin Ristl; Kornelia Vigl; Susanne Kimeswenger; Katharina Neubauer; Detlev Pirkhammer; Martin Zikeli; Wolfram Hoetzenecker; Norbert Reider; Christine Bangert
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.